BCAB

BioAtlaB

Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences

At close

2026-07-22

View Chart

Peers tracked

U.S. public peers

Grade Position

Above peers

vs peer average

BCAB vs peer average

87/100

BCAB vs. peer average (B vs. D)

Grade spread

B 1 · D 4 · F 5

Graded peers loaded

Coverage

10 graded

100% of tracked

Peer overview

APVO is the first available peer comparator.

Micro-cap oncology biotech peer useful for framing financing sensitivity, restructuring risk, and event-driven trading, though pipeline overlap is limited.

✓Peer source comes from the stored AI memo or peer model

✓Grades and factor rows use RankAlpha API data when available

✓Missing peer scores remain blank instead of being estimated

✓Side-by-side comparison keeps the data contract visible

Top peerAPVOAptevo Therapeutics

BCAB

BioAtla

APVO

Aptevo Therapeutics

Grade

Momentum

Value

Sentiment

Setup Bias

Net —

Market Cap

Posture

Constructive

Defensive

Open Side-by-Side Comparison Compare all

Grade position vs APVO

BCAB / APVO

Grade Position

Above peers

BCAB vs. peer average (B vs. D)

87/100

Momentum

BCAB

Value

APVO

Sentiment

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank

Ticker

Company

Grade

Grade score

vs BCAB

APVO

40/100

PCSA

20/100

GOVX

80/100

Even

NCNA

NuCana plc ADR

40/100

SNOA

Sonoma Pharmaceuticals Inc Common

40/100

APVO is the first peer returned for this comparison set.